BlackRock Group’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-17,639
Closed -$57K 3111
2016
Q1
$57K Buy
17,639
+6,879
+64% +$25.4K ﹤0.01% 2894
2015
Q4
$51K Sell
10,760
-329
-3% -$1.86K ﹤0.01% 2823
2015
Q3
$62K Buy
11,089
+3,461
+45% +$25.5K ﹤0.01% 2813
2015
Q2
$61K Buy
7,628
+2,050
+37% +$17.6K ﹤0.01% 2851
2015
Q1
$59K Buy
5,578
+1,968
+55% +$26.9K ﹤0.01% 2750
2014
Q4
$43K Buy
+3,610
New +$54.9K ﹤0.01% 2797

Other funds holding BDSI

BlackRock Group's BDSI Position: Q2 2016 in Review

BlackRock Group sold out of BioDelivery Sciences International, Inc. (BDSI) in Q2 2016, closing a stake of 17,639 shares — an estimated $57K sold.

BlackRock Group first reported a position in BDSI in Q4 2014 and held it in 6 quarters. The position peaked at $62K in Q3 2015. 88 funds tracked by Wall St. Rank hold BDSI as of Q2 2016.

  • BlackRock Group reported no remaining BioDelivery Sciences International, Inc. position as of Q2 2016 after selling out during the quarter.
  • BlackRock Group sold 17,639 BioDelivery Sciences International, Inc. shares in Q2 2016, an estimated $57K.
  • BlackRock Group first reported a position in BioDelivery Sciences International, Inc. in Q4 2014 and held it in 6 quarters.
  • BlackRock Group's BioDelivery Sciences International, Inc. position peaked at $62K in Q3 2015.
  • 88 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q2 2016.

Based on BlackRock Group's 13F filing for Q2 2016, filed 10 Aug 2016.